Furthermore, breast cancer patients with a TLR4 loss‐of‐function allele, that prevents HMGB1 binding to TLR4, are more prone to relapse after radiotherapy or chemotherapy [50]. This evidence concerns the gene TLR4 and breast carcinoma.